Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
922studies shown
Showing 601-625 of 922
RecruitingISRCTN55488371

Computerised Cognitive Remediation Therapy for Schizophrenia

This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN25898179

Rehabilitation Effectiveness for Activities for Life

This study is looking at whether Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 can help people with psychosis. Participants take part in Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
University College London (UK)
Condition
Schizophrenia
RecruitingISRCTN84216587

Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London and Barts and the London NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN32434568

OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Finland, Italy
Sponsor
University of Oxford (UK)
Condition
Schizophrenia
RecruitingISRCTN94846422

An intervention to improve psychiatrist-patient communication

This study is looking at whether a digital support tool can help people with Schizophrenia/schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London (UK)
Condition
Schizophrenia
RecruitingISRCTN56877013

A randomised trial comparing the clinical and cost effectiveness of usual, facility based care compared to an additional collaborative community care package for people and their families living with schizophrenia in India

This study is looking at whether a digital support tool can help people with Mental health/schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, India
Sponsor
Kings College London (UK)
Condition
Schizophrenia
RecruitingISRCTN62599190

Comparison of training methods in dual diagnosis (mental health and substance use) treatment for community mental health teams

This study is looking at whether This is an intention to treat, repeated measure within subjects randomised trial can help people with Schizophrenia, co-morbid drug and alcohol dependence, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
University College London (UK)
Condition
Schizophrenia
RecruitingISRCTN33909010

A phase 3 randomised placebo- and active comparator-controlled, clinical trial to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic patients with schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Bulgaria, Colombia, India, Lithuania, Peru, Philippines, Serbia
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN16838597

A phase three randomised, placebo-controlled, clinical trial to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic patients with schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, France, India, Malaysia, Romania, Russian Federation, Ukraine, United States
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN97049967

Phase 3 long-term safety, tolerability and effectiveness of lurasidone in subjects with schizophrenia or schizoaffective disorder

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United Kingdom, Argentina, Brazil, Chile, Croatia, Israel, South Africa, Thailand
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN93378085

Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Condition
Schizophrenia
RecruitingISRCTN65536352

Cognitive Behavioural Case Management (CBCM) in First-Episode Schizophrenia and Related Psychotic Disorders - a pilot study

This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Condition
Schizophrenia
RecruitingISRCTN11138647

Relapse Prevention Group Programme for service users with an international statistical classification of diseases and related health problems (ICD10, chapter F20) diagnosis of schizophrenia in a community setting - a randomised controlled trial

This study is looking at whether Relapse prevention programme as opposed to treatment as usual can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Relapse prevention programme as opposed to treatment as usual and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Brent Mental Health Service (UK)
Condition
Schizophrenia
RecruitingISRCTN75187865

Cognitive remediation for young people with schizophrenia

This study is looking at whether Cognitive remediation therapy versus usual care can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive remediation therapy versus usual care and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London (UK)
Condition
Schizophrenia
RecruitingISRCTN46561083

Reasoning and rehabilitation in mentally disordered offenders: a pilot randomised controlled trial

This study is looking at whether Reasoning and rehabilitation programme versus treatment as usual can help people with Schizophrenia or schizoaffective disorder or Mental and Behavioural Disorders. Participants take part in Reasoning and rehabilitation programme versus treatment as usual and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
The Institute of Psychiatry (UK)
Condition
Schizophrenia
RecruitingISRCTN72416821

Modernising teams service delivery: implementing the NICE schizophrenia guideline

This study is looking at whether Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Schizophrenia
RecruitingISRCTN42505388

The London East Anglia randomised controlled trial for cognitive-behaviour therapy for psychosis: effects of the treatment phase

This study is testing a medication approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition
Schizophrenia